Skip to main content
Your Health
Therapeutic Areas
TD Awareness
Our Science
Pipeline
Clinical Studies
Emerging Fields
Advancing Science
Medicines
Our Company
About Us
Leadership
News & Media
Our Responsibility
Belonging, Respect and Empowerment
Funding & Support Requests Portal
Careers
Meet Our People
Work With Us
Total Rewards
Investors
Investors Overview
News Releases
Webcasts & Presentations
Financial Communications
SEC Filings
Annual Meeting
Annual Reports
Corporate Governance
Responsibility
Stock Information
Stock Quote
Shareholder Contacts
Analyst Coverage
MENU
CLOSE
Close
Search
Your Health
Therapeutic Areas
TD Awareness
Our Science
Pipeline
Clinical Studies
Emerging Fields
Advancing Science
Medicines
Our Company
About Us
Leadership
News & Media
Our Responsibility
Belonging, Respect and Empowerment
Funding & Support Requests Portal
Careers
Meet Our People
Work With Us
Total Rewards
Investors
Investors Overview
News Releases
Webcasts & Presentations
Financial Communications
SEC Filings
Annual Meeting
Annual Reports
Corporate Governance
Responsibility
Stock Information
Stock Quote
Shareholder Contacts
Analyst Coverage
2026-06-10
Neurocrine Biosciences Annual Meeting materials including proxy statement and annual report.
Annual Meeting
2026 Proxy Statement
2025 Annual Report
Close
You are now leaving Neurocrine.com.
Go Back
Exit Site
Top
